Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Change in Accured Expenses (2017 - 2025)

Historic Change in Accured Expenses for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to -$748246.0.

  • Selectis Health's Change in Accured Expenses fell 21083.02% to -$748246.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $720350.0, marking a year-over-year decrease of 6514.06%. This contributed to the annual value of $528834.0 for FY2024, which is 7797.78% down from last year.
  • According to the latest figures from Q3 2025, Selectis Health's Change in Accured Expenses is -$748246.0, which was down 21083.02% from -$151200.0 recorded in Q2 2025.
  • Over the past 5 years, Selectis Health's Change in Accured Expenses peaked at $1.9 million during Q4 2021, and registered a low of -$2.0 million during Q3 2022.
  • Moreover, its 5-year median value for Change in Accured Expenses was $238906.0 (2024), whereas its average is $211584.5.
  • As far as peak fluctuations go, Selectis Health's Change in Accured Expenses surged by 104569.12% in 2021, and later crashed by 97200.09% in 2022.
  • Quarter analysis of 5 years shows Selectis Health's Change in Accured Expenses stood at $1.9 million in 2021, then plummeted by 36.14% to $1.2 million in 2022, then skyrocketed by 37.07% to $1.6 million in 2023, then plummeted by 94.31% to $92753.0 in 2024, then plummeted by 906.71% to -$748246.0 in 2025.
  • Its last three reported values are -$748246.0 in Q3 2025, -$151200.0 for Q2 2025, and $1.5 million during Q1 2025.